Hui Li Ang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hui Li Ang

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Pharmaceutics|November 14, 2020

Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor ActivityMilad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, et al.

Life Sciences|March 8, 2022

Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapyMahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 27, 2021

Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical deliveryMilad Ashrafizadeh, Ali Zarrabi, Sepideh Mirzaei, et al.

Alzheimer'S Research & Therapy|October 1, 2020

Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairmentXin Ying Chua, Yuek Ling Chai, Wee Siong Chew, et al.

Theranostics|January 4, 2021

Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.

Journal of Hematology & Oncology|January 13, 2025

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Pharmaceutics|November 14, 2020

Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor ActivityMilad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, et al.

Life Sciences|March 8, 2022

Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapyMahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 27, 2021

Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical deliveryMilad Ashrafizadeh, Ali Zarrabi, Sepideh Mirzaei, et al.

Alzheimer'S Research & Therapy|October 1, 2020

Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairmentXin Ying Chua, Yuek Ling Chai, Wee Siong Chew, et al.

Theranostics|January 4, 2021

Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.

Journal of Hematology & Oncology|January 13, 2025

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.

Pageof 2